Sars-cov-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in covid-19

HIGHLIGHTS

• who: Daniel J. Clemens and collaborators from the Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States of America Editor: MJohnson, Open University have published the Article: SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19, in the Journal: PLOS ONE of August/17,/2022
• what: The authors determined the electrophysiological effects, cytosolic calcium handling, and arrhythmic potential, of direct SARS-CoV-2 infection of the heart in the ACE2-accentuated, bio-engineered hiPSC-CM model system.
• how: Data were analyzed using . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.